And PAR get none of that money...they are supplying it for free....

And PAR get none of that money...they are supplying it for free. They will be building and preparing supplies and repackaging for the vials to match placebo etc and unfortunately giving the medication out for free is not what I want the company to continue doing at this stage of the game (does anyone want this who has an interest in the company long-term?) - it’s not in shareholders best interest. Of course those that are approved should be supplied but the cat is out of the bad and I’m sure there’s will be thousands of people wanting to line up to inject this medication and charge $1600 for the job - seems like a bit much to me - pretty sure you get about that from Medicare for doing a knee replacement surgery......

Have a think about what you want the company to be doing for the long term benefit of the likely millions that can be treated if they focus on the trials and keep their funds for that purpose at this stag of development. We have been told over and over that there won’t be supply issues long term but why should they be ramping up production prior to results coming? Why should they continue to give out free medication now that the data has reached the stage of FDA trial progress.